Clinical Trial Management System CTMS Market Size, Share, Key Players, Growth Trend, Application Forecast 2030

Posted November 23, 2021 by bhandvalkar94

The worldwide Clinical Trial Management System CTMS market has recently been published by Absolute Markets Insights.
The worldwide Clinical Trial Management System CTMS market has recently been published by Absolute Markets Insights. The statistical report offers an appropriate analysis of recent trends and technological advancements in global regions such as North America, Latin America, Asia-Pacific, Africa, and India. The data also uses useful tools, methodologies and standard operating procedures carried out by top-level industries to support its analysis. Moreover, the study also applies effective exploratory techniques such as primary and secondary research techniques. Some of the distinctive market key components of the global Clinical Trial Management System CTMS market have been studied in order to get an extensive idea about the requirements of the businesses. Financial and economic aspects of the businesses have also been presented by means of graphical presentation techniques such as charts, graphs, tables, and pictures. The entire demand and supply chain has been explained with the help of penetrative insights into the businesses.

Top Players of Global Clinical Trial Management System CTMS Market are Studied: Bio Clinica, Medidata Solutions, DataTrak Internationals, Bio-Optronics, Merge Healthcare (IBM Watson), DSG, Forte Research Systems, MedNet Solutions, Omnicomm Systems, Oracle, MasterControl, Parexel Informatics and Veeva Systems

Click to view the full report:

Global clinical trial management system (CTMS) market was valued at US$ 727.54 million in 2020 and is expected to reach US$ 2478.15 million by 2030, growing at an estimated CAGR of +14.6% over the forecast period (2021-2030). Rising number of clinical trials is driving the clinical trial management system market. Increase in the number of clinical trials each year is witnessed by the life science industry. This growth in the CTMS market can be attributed to factors such as high popularity of chronic diseases, government funds availability for clinical trials, increasing R&D investment in pharmaceutical industry.

Based on end user, clinical trial management system (CTMS) market is segmented into, pharmaceutical & biopharmaceutical companies, clinical research organizations, and healthcare providers.The category of clinical research organizations is expected to grow is with a significant CAGR over the forecast period. Growth of the segment is accelerated due to the growing acceptance of clinical trial management systems in the new drug development process for clinical studies. Collaborations between biopharmaceutical companies and clinical research organizations (CROs) is responsible for increasing the number of ongoing clinical trials. Rising government grants to support clinical trials, availability of innovative , clinical trial management system (CTMS) solutions and growing customer base for Clinical Trial Management System (CTMS) Market solutions are the major factors responsible for the adoption of clinical trial management system by pharmaceutical and biopharmaceutical firms and ultimately promising growth in the future.

Clinical Trial Management System (CTMS) in Healthcare Market:

By Component type

By Delivery mode

By Product

Enterprise Based
Site Based Services
By End-user

Pharmaceutical & Biopharmaceutical Companies
Clinical Research Organizations
Healthcare Providers
By Region

North America
Asia Pacific
Middle East and Africa
Latin America
Contact Us:

Company: Absolute Markets Insights

Email id: [email protected]

Phone: +91-740-024-2424

Contact Name: Shreyas Tanna

-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Kavita Sharma
Country India
Categories Business
Tags clinical trial management system ctms market
Last Updated November 23, 2021